[Mechanism of action of dipyridamole: inhibition by dipyridamole of adenosine uptake in erythrocytes]
- PMID: 4243212
[Mechanism of action of dipyridamole: inhibition by dipyridamole of adenosine uptake in erythrocytes]
Similar articles
-
Kinetics of adenosine uptake by erythrocytes, and the influence of dipyridamole.Mol Pharmacol. 1972 Jul;8(4):417-25. Mol Pharmacol. 1972. PMID: 5053581 No abstract available.
-
[Species differences with respect to influencing the action and elimination of adenosine by dipyridamole and hexobendine].Naunyn Schmiedebergs Arch Pharmakol. 1970;266(4):373-4. Naunyn Schmiedebergs Arch Pharmakol. 1970. PMID: 4253808 German. No abstract available.
-
[On the explanation of the mechanism of action of dipyridamole].Arzneimittelforschung. 1969 Jan;19(1):97-8. Arzneimittelforschung. 1969. PMID: 5819371 German. No abstract available.
-
Specificity of adenosine uptake into the heart and inhibition by dipyridamole.Eur J Pharmacol. 1970 Mar;9(3):265-8. doi: 10.1016/0014-2999(70)90221-9. Eur J Pharmacol. 1970. PMID: 5440297 No abstract available.
-
[Contents and role of adenosine in the heart and blood vessels].Pol Tyg Lek. 1971 Jun 14;26(4):926-9. Pol Tyg Lek. 1971. PMID: 4948279 Review. Polish. No abstract available.
Cited by
-
The effects of dipyridamole on the myocardial vasodilator actions of noradrenaline, isoprenaline and adenosine.Br J Pharmacol. 1972 Dec;46(4):585-93. doi: 10.1111/j.1476-5381.1972.tb06885.x. Br J Pharmacol. 1972. PMID: 4655263 Free PMC article.
-
Pharmacokinetics of oral dipyridamole (Persantine) and its effect on platelet adenosine uptake in man.Eur J Clin Pharmacol. 1982;23(3):229-34. doi: 10.1007/BF00547559. Eur J Clin Pharmacol. 1982. PMID: 6756935 Clinical Trial.
-
Binding of dipyridamole to human platelets and to alpha1 acid glycoprotein and its significance for the inhibition of adenosine uptake.J Clin Invest. 1977 Oct;60(4):936-43. doi: 10.1172/JCI108848. J Clin Invest. 1977. PMID: 893681 Free PMC article.
-
The pivotal role of the mitochondrial amidoxime reducing component 2 in protecting human cells against apoptotic effects of the base analog N6-hydroxylaminopurine.J Biol Chem. 2015 Apr 17;290(16):10126-35. doi: 10.1074/jbc.M115.640052. Epub 2015 Feb 23. J Biol Chem. 2015. PMID: 25713076 Free PMC article.